Literature DB >> 16160180

The transmembrane domain of the respiratory syncytial virus F protein is an orientation-independent apical plasma membrane sorting sequence.

Sean C Brock1, Josh M Heck, Patricia A McGraw, James E Crowe.   

Abstract

The processes that facilitate transport of integral membrane proteins though the secretory pathway and subsequently target them to particular cellular membranes are relevant to almost every field of biology. These transport processes involve integration of proteins into the membrane of the endoplasmic reticulum (ER), passage from the ER to the Golgi, and post-Golgi trafficking. The respiratory syncytial virus (RSV) fusion (F) protein is a type I integral membrane protein that is uniformly distributed on the surface of infected nonpolarized cells and localizes to the apical plasma membrane of polarized epithelial cells. We expressed wild-type or altered RSV F proteins to gain a better understanding of secretory transport and plasma membrane targeting of type I membrane proteins in polarized and nonpolarized epithelial cells. Our findings reveal a novel, orientation-independent apical plasma membrane targeting function for the transmembrane domain of the RSV F protein in polarized epithelial cells. This work provides a basis for a more complete understanding of the role of the transmembrane domain and cytoplasmic tail of viral type I integral membrane proteins in secretory transport and plasma membrane targeting in polarized and nonpolarized cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160180      PMCID: PMC1211512          DOI: 10.1128/JVI.79.19.12528-12535.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein.

Authors:  B M Ward; B Moss
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Membrane traffic in polarized epithelial cells.

Authors:  K E Mostov; M Verges; Y Altschuler
Journal:  Curr Opin Cell Biol       Date:  2000-08       Impact factor: 8.382

Review 3.  Protein trafficking in the exocytic pathway of polarized epithelial cells.

Authors:  W J Nelson; C Yeaman
Journal:  Trends Cell Biol       Date:  2001-12       Impact factor: 20.808

Review 4.  Topogenesis of membrane proteins: determinants and dynamics.

Authors:  V Goder; M Spiess
Journal:  FEBS Lett       Date:  2001-08-31       Impact factor: 4.124

Review 5.  Polarized epithelial membrane traffic: conservation and plasticity.

Authors:  Keith Mostov; Tao Su; Martin ter Beest
Journal:  Nat Cell Biol       Date:  2003-04       Impact factor: 28.824

6.  Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation.

Authors:  Lewis H McCurdy; Barney S Graham
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  Analysis of the transmembrane domain of influenza virus neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association.

Authors:  S Barman; D P Nayak
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  Roles for the cytoplasmic tails of the fusion and hemagglutinin-neuraminidase proteins in budding of the paramyxovirus simian virus 5.

Authors:  David L Waning; Anthony P Schmitt; George P Leser; Robert A Lamb
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

9.  Trafficking of tail-anchored proteins: transport from the endoplasmic reticulum to the plasma membrane and sorting between surface domains in polarised epithelial cells.

Authors:  Alessandra Bulbarelli; Teresa Sprocati; Massimo Barberi; Emanuela Pedrazzini; Nica Borgese
Journal:  J Cell Sci       Date:  2002-04-15       Impact factor: 5.285

Review 10.  The tale of tail-anchored proteins: coming from the cytosol and looking for a membrane.

Authors:  Nica Borgese; Sara Colombo; Emanuela Pedrazzini
Journal:  J Cell Biol       Date:  2003-06-23       Impact factor: 10.539

View more
  23 in total

1.  The human respiratory syncytial virus matrix protein is required for maturation of viral filaments.

Authors:  Ruchira Mitra; Pradyumna Baviskar; Rebecca R Duncan-Decocq; Darshna Patel; Antonius G P Oomens
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

2.  The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis.

Authors:  Julia Eckardt-Michel; Markus Lorek; Diane Baxmann; Thomas Grunwald; Günther M Keil; Gert Zimmer
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

3.  The respiratory syncytial virus fusion protein targets to the perimeter of inclusion bodies and facilitates filament formation by a cytoplasmic tail-dependent mechanism.

Authors:  Pradyumna S Baviskar; Anne L Hotard; Martin L Moore; Antonius G P Oomens
Journal:  J Virol       Date:  2013-07-31       Impact factor: 5.103

4.  Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cells.

Authors:  Melissa Batonick; Antonius G P Oomens; Gail W Wertz
Journal:  J Virol       Date:  2008-06-18       Impact factor: 5.103

5.  Vectorial entry and release of hepatitis A virus in polarized human hepatocytes.

Authors:  Michelle J Snooks; Purnima Bhat; Jason Mackenzie; Natalie A Counihan; Nicola Vaughan; David A Anderson
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

Review 6.  Trafficking to the apical and basolateral membranes in polarized epithelial cells.

Authors:  Emily H Stoops; Michael J Caplan
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

7.  Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.

Authors:  Bo Liang; Joan O Ngwuta; Richard Herbert; Joanna Swerczek; David W Dorward; Emerito Amaro-Carambot; Natalie Mackow; Barbora Kabatova; Matthias Lingemann; Sonja Surman; Lijuan Yang; Man Chen; Syed M Moin; Azad Kumar; Jason S McLellan; Peter D Kwong; Barney S Graham; Anne Schaap-Nutt; Peter L Collins; Shirin Munir
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 8.  Molecular mechanisms driving respiratory syncytial virus assembly.

Authors:  Fyza Y Shaikh; James E Crowe
Journal:  Future Microbiol       Date:  2013-01       Impact factor: 3.165

9.  Reversion of somatic mutations of the respiratory syncytial virus-specific human monoclonal antibody Fab19 reveal a direct relationship between association rate and neutralizing potency.

Authors:  John T Bates; Christopher J Keefer; Thomas J Utley; Bruno E Correia; William R Schief; James E Crowe
Journal:  J Immunol       Date:  2013-03-01       Impact factor: 5.422

10.  A recombinant influenza virus vaccine expressing the F protein of respiratory syncytial virus.

Authors:  Wendy Fonseca; Makoto Ozawa; Masato Hatta; Esther Orozco; Máximo B Martínez; Yoshihiro Kawaoka
Journal:  Arch Virol       Date:  2013-12-01       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.